BIOMAT Database Logo BIOMAT Database Logo

[Effect of acute furosemide and sodium chloride load on the hormone level of the blood of ischemic heart disease patients]. 1982

I B Livshits

In group of 43 patients with ischaemic heart disease and coronary atherosclerosis and in 18 practically healthy individuals administration of a single intravenous dose of furosemide (40 mg) in one group, and of 10 ml 10% sodium chloride in the other was employed to study the activity of various hormones in the blood. It was established that in patients with ischaemic heart disease dissociation of the functional state of the hormonal systems, ensuring integration of the main haemodynamic and water-salt parameters takes place. The degree of lesion of these adaptive mechanisms is related to the severity of the disease, its duration, and the initial hormonal background. Furosemide and sodium chloride given in these doses permit to detect more clearly the disorders supervening in these systems.

UI MeSH Term Description Entries
D008297 Male Males
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012965 Sodium Chloride A ubiquitous sodium salt that is commonly used to season food. Sodium Chloride, (22)Na,Sodium Chloride, (24)NaCl

Related Publications

I B Livshits
[Effect of acute furosemide load on the level of blood prostaglandins in healthy persons and patients with hypertension].
January 1978, Terapevticheskii arkhiv,
I B Livshits
[Effect of acute sodium chloride load on blood prostaglandin levels in healthy subjects and in patients with hypertension].
January 1980, Terapevticheskii arkhiv,
I B Livshits
[Effect of comprehensive treatment, including Azatavan sodium chloride-iodobromine mineral baths, on ischemic heart disease patients].
January 1979, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
I B Livshits
[Effect of sodium chloride on blood cholesterol level in patients with atherosclerosis].
January 1961, Klinicheskaia meditsina,
I B Livshits
[Effect of threshold physical exercise on blood lipid level in patients with ischemic heart disease].
August 1985, Kardiologiia,
I B Livshits
[The effect of sodium chloride baths on the physical work capacity and extrasystole of patients with ischemic heart disease and stable stenocardia].
January 1999, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
I B Livshits
[Effect of sodium load and furosemide administration on the chronic type of the syndrome of inappropriate secretion of antidiuretic hormone].
June 1987, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
I B Livshits
The mechanism of the acute effect of sodium chloride on blood pressure.
February 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
I B Livshits
Effect of physical load on the platelet function and ultrastructure in patients with ischemic heart disease.
January 1992, Acta Universitatis Palackianae Olomucensis Facultatis Medicae,
I B Livshits
[The level of somatotropic hormone and cortisol in the blood of patients with ischemic heart disease and a rhythm disorder].
January 1997, Likars'ka sprava,
Copied contents to your clipboard!